Health Catalyst Inc. /zigman2/quotes/213268802/composite HCAT +0.03% disclosed Friday terms for its initial public offering, in which the Salt Lake City-based data and analytics technology services for the health care industry is looking to raise up to $138 million. The company is offering 6 million shares in the IPO, which is expected to price between $20 and $23. The stock is expected to list on the Nasdaq Global Select Market under the ticker symbol "HCAT." With 34.1 million shares outstanding after the IPO, the company would be valued at up to $783.8 million. Goldman Sachs, J.P. Morgan and William Blair are the lead underwriters. The company estimates second-quarter 2019 losses from operations of $10.3 million to $9.3 million on revenue of $19.6 million to $20.1 million, after a loss of $18.8 million on revenue of $10.7 million in same period a year ago. The company is looking to go public at a time the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO +1.91% has gained 4.6% over the past three months, while the SPDR Health Care Select Sector ETF /zigman2/quotes/205918244/composite XLV -0.21% has advanced 3.0% and the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.05% has tacked on 3.3%.
This replaces an earlier item that incorrectly reported the time period for the financial results. It has been corrected.